Antibacterial compounds and uses thereof

US10508097B2 · kind B2 · utility

Assignees

• The Global Alliance for TB Drug Development, Inc. · US
• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Anna Marie Upton · New York, US
• Christopher B. Cooper · Lawrenceville, US
• Koenraad Jozef Lodewijk Marcel Andries · Beerse, BE
• Jérôme Emile Georges Guillemont · Andé, FR
• Walter Marcel Mathilde Van den Broeck · Vilvoorde, BE
• Brian Desmond Palmer · Auckland, NZ
• Zhenkun Ma · Westfield, US

Key dates

• Filing date: Mar 7, 2017
• Grant date: Dec 17, 2019
• Expiry date: Mar 7, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to compounds of formula (I) including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of tuberculosis.